Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Timeline
  • Published:

Raising the profile of genetics in primary care

Abstract

Primary care practitioners recognize that genetics is relevant to their daily practice, for example, for detecting and managing the risk of multifactorial disorders and genetic reproductive risks, and, in future, for targeted drug therapy. However, they lack confidence in their ability to apply genetic approaches. In fact, genetics is already ingrained in current practice, and the development of appropriate guidelines and web-based information resources will help practitioners to make personalized genetic risk assessment a part of holistic, patient-oriented primary health care.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Difficulty of disentangling genetic and environmental influences on disease in families.
Figure 2: Ways of using pedigrees in medical genetics care.
Figure 3: Four stages of antenatal screening.

References

  1. Osler, W. The Principles and Practice of Medicine. (Young J. Pentland, Edinburgh, 1895).

    Google Scholar 

  2. Haldane, J. B. S. New Paths in Genetics (George Allan and Unwin, London, 1941).

    Google Scholar 

  3. Resta, R. G. & Paul, D. Historical aspects of medical genetics. Am. J. Med. Genet. 115, 73–74 (2002).

    Article  Google Scholar 

  4. Scheuner, M. T., Wang, S. J., Raffel, L. J., Larabell, S. K. & Rotter, J. I. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am. J. Med. Genet. 71, 315–324 (1997).

    Article  CAS  Google Scholar 

  5. Huygen, F. J. A. Family Medicine: the Medical Life History of Families (Dekker & Van de Vegt, Nijmegen, 1978).

    Google Scholar 

  6. Geyman, J. P. The family as the object of care in family practice. J. Fam. Pract. 5, 571–575 (1977).

    CAS  PubMed  Google Scholar 

  7. McDaniel, S. H., Campbell, T. L. & Seaburn, D. B. Family-Orientated Primary Care: a Manual for Medical Providers (Springer, New York, 1990).

    Book  Google Scholar 

  8. Kuenssberg, E. V. Recording of morbidity of families. J. R. Coll. Gen. Pract. 7, 410–422 (1964).

    CAS  Google Scholar 

  9. Qureshi, N., Gilbert, P. & Raeburn, J. A. Consanguinity and genetic morbidity in a British primary care setting: a pilot study with trained linkworkers. Ann. Hum. Biol. 30, 140–147 (2003).

    Article  CAS  Google Scholar 

  10. Rose, P., Humm, E., Hey, K., Jones, L. & Huson, S. M. Family history taking and genetic counselling in primary care. Fam. Pract. 16, 78–83 (1999).

    Article  CAS  Google Scholar 

  11. Frezzo, T. M., Rubinstein, W. S., Dunham, D. & Ormond, K. E. The genetic family history as a risk assessment tool in internal medicine. Genet. Med. 5, 84–91 (2003).

    Article  Google Scholar 

  12. Modell B. & Modell M. Towards a Healthy Baby– Congenital Disorders and the New Genetics in Primary Care (Oxford Univ. Press, Oxford, 1993).

    Google Scholar 

  13. Hapgood, R. H. The potential and limitations of personalised medicine in primary care. Br. J. Gen. Pract. 53, 915–916 (2003).

    PubMed  PubMed Central  Google Scholar 

  14. Expert Panel on Detection. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).

  15. Department of Health. National Service Framework for Diabetes: Standards <http://www.dh.gov.uk/assetRoot/04/05/89/38/04058938.pdf> (Department of Health, London, 2001).

  16. Watson, E. et al. Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial. Br. J. Gen. Pract. 51, 817–821 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Rose, P. W. et al. Improving the ascertainment of families at high risk of colorectal cancer: a prospective GP register study. Br. J. Gen. Pract. 54, 267–271 (2004).

    PubMed  PubMed Central  Google Scholar 

  18. Pharoah, P. D. P., Stratton, J. F. & Mackay, J. Screening for breast and ovarian cancer: the relevance of family history. Br. Med. Bull. 54, 823–838 (1998).

    Article  CAS  Google Scholar 

  19. Vasen, H. F., Watson, P., Mecklin, J. P. & Lynch, H. T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116, 1453–1456 (1999).

    Article  CAS  Google Scholar 

  20. Qureshi, N. & Raeburn, J. A. Clinical genetics meets primary care. Br. Med. J. 307, 816–817 (1993).

    Article  CAS  Google Scholar 

  21. Mouzouras, M. et al. Thalassaemia as a model of recessive genetic disease in the community. Lancet 2, 574–578 (1980).

    Article  CAS  Google Scholar 

  22. Smith, I., Cook, B. & Beasley, M. Review of neonatal screening programme for phenylketonuria. Br. Med. J. 303, 333–335 (1991).

    Article  CAS  Google Scholar 

  23. Grant, D. B. & Smith, I. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982–4. Br. Med. J. 296, 1355–1358 (1988).

    Article  CAS  Google Scholar 

  24. Murray, J., Cuckle, H., Taylor, G., Littlewood, J. & Hewison, J. Screening for cystic fibrosis. Health Technol. Assess. 3, 1–104 (1999).

    Google Scholar 

  25. Gulbis, B., Tshilolo, L., Cotton, F., Lin, C. & Vertongen, F. Newborn screening for haemoglobinopathies: the Brussels experience. J. Medic. Screen. 6, 11–15 (1999).

    Article  CAS  Google Scholar 

  26. Seymour, C. A. et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol. Assess. 1, 1–95 (2001).

    Google Scholar 

  27. Bowman, J. M. & Pollack, J. M. Amniotic fluid spectrophotometry and early delivery in the management of erythroblastosis fetalis. Pediatrics 35, 815–832 (1965).

    CAS  PubMed  Google Scholar 

  28. Clarke, C. A. & Sheppard, P. M. Prevention of rhesus haemolytic disease. Lancet 19, 343 (1965).

    Article  Google Scholar 

  29. Rodeck, C. H. & Whittle, M. J. Fetal Medicine. Basic Science and Clinical Practice (Churchill Livingstone, London, 1999).

    Google Scholar 

  30. Leuzzi, R. A. & Scoles, K. S. Preconception counseling for the primary care physician. Med. Clin. North Am. 80, 337–374 (1996).

    Article  CAS  Google Scholar 

  31. Kaback, M. M., Zeiger, R. S., Reynolds, L. W. & Sonneborn, M. Approaches to the control and prevention of Tay–Sachs disease. Prog. Med. Genet. 10, 103–134 (1974).

    CAS  PubMed  Google Scholar 

  32. Mennie, M. E. et al. Prenatal screening for cystic fibrosis. Lancet 340, 214–216 (1992).

    Article  CAS  Google Scholar 

  33. Angastiniotis, M. A. & Hadjiminas, M. G. Prevention of thalassaemia in Cyprus. Lancet 1, 369–371 (1981).

    Article  CAS  Google Scholar 

  34. World Health Organization. Community control of hereditary anaemias: memorandum from a WHO meeting. Bull. World Health Organ. 61, 63–80 (1983).

  35. Alwan, A. & Modell, B. Recommendations for introducing genetics services in developing countries. Nature Rev. Genet. 4, 61–68 (2003).

    Article  CAS  Google Scholar 

  36. Greengross, P., Hickman, M., Gill, M., Dugan, B. & Davies, S. C. Outcomes of universal antenatal screening for haemoglobinopathies. J. Medic. Screen. 6, 3–10 (1999).

    Article  CAS  Google Scholar 

  37. Modell, B. et al. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. Br. Med. J. 320, 337–41 (2000)

    Article  CAS  Google Scholar 

  38. Lipkin, M. Jr, Fisher, L., Rowley, P. T., Loader, S. & Iker, H. P. Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for β-thalassemia trait. Ann. Intern. Med. 105, 115–123 (1986).

    Article  Google Scholar 

  39. Modell, M. et al. A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disorders. Br. Med. J. 317, 788–791 (1998).

    Article  CAS  Google Scholar 

  40. Watson, E. K. et al. Screening for carriers of cystic fibrosis through primary health care services. Br. Med. J. 303, 504–507 (1991).

    Article  CAS  Google Scholar 

  41. Modell, M., Khan, M., Modell, B. & Wonke, B. Why do some practices respond to an educational intervention? Br. J. Gen. Pract. 50, 826–827 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Modell, B. & Darr, A. Genetic counselling and customary consanguineous marriage. Nature Rev. Genet. 3, 225–229 (2002).

    Article  CAS  Google Scholar 

  43. Kardia, S. L. R., Modell, S. M. & Peyser, P. A. Family-centered approaches to understanding and preventing coronary heart disease. Am. J. Prev. Med. 24, 128–135 (2003).

    Article  Google Scholar 

  44. Yoon, P. W., Scheuner, M. T. & Khoury, M. J. Research priorities for evaluating family history in the prevention of common chronic diseases. Am. J. Prev. Med. 24, 143–151 (2003).

    Article  Google Scholar 

  45. Watson, E. K. et al. The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam. Pract. 16, 420–425 (1999).

    Article  CAS  Google Scholar 

  46. Qureshi, N., Hapgood, R. & Armstrong, S. Continuous medical education approaches for clinical genetics: a postal survey of general practitioners. J. Med. Genet. 39, e69 (2002).

    Article  CAS  Google Scholar 

  47. Bankhead, C. et al. New developments in genetics — Knowledge, attitudes and information needs of practice nurses. Fam. Pract. 18, 475–486 (2001).

    Article  CAS  Google Scholar 

  48. Metcalfe, S., Hurworth, R., Newstead, J. & Robins, R. Needs assessment study of genetics education for general practitioners in Australia. Genet. Med. 4, 71–77 (2002).

    Article  Google Scholar 

  49. Mitchell, J. J., Capua, A., Clow, C. & Scriver, C. R. Twenty-year outcome analysis of genetic screening programs for Tay–Sachs and β-thalassemia disease carriers in high schools. Am. J. Hum. Genet. 59, 793–798 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Vermeulen, E. G. et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 355, 517–522 (2000).

    Article  CAS  Google Scholar 

  51. Harrison, T. A. et al. Family history of diabetes as a potential public health tool. Am. J. Prev. Med. 24, 152–159 (2003).

    Article  Google Scholar 

  52. Gottesman, M. M. & Collins, F. S. The role of the human genome project in disease prevention. Prev. Med. 23, 591–594 (1994).

    Article  CAS  Google Scholar 

  53. Penrose, L. S. Outline of Human Genetics (Heinemann, London, 1959).

  54. Christianson, A. & Modell, B. Medical genetics in developing countries. Annu. Rev. Genomics Hum. Genet. 5, 219–265 (2004).

    Article  CAS  Google Scholar 

  55. Department of Health, UK Department of Health Genetics White Paper — Our inheritance; realising the potential of genetics in the NHS <http://www.dh.gov.uk/assetRoot/04/01/92/39/04019239.pdf> (Department of Health, London, 2003).

Download references

Acknowledgements

We thank Maren Khan for allowing us to use her data in figure 3. N.Q. received a proportion of his funding from the NHS Research and Development levy and from the Commonwealth Fund, New York; the views expressed in this publication are those of the authors and not necessarily those of the NHS executive or the Commonwealth Fund, its directors, officers or staff.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nadeem Qureshi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

DATABASES

International database on the legal, social and ethical aspects of human genetics, maintained by the University of Montreal

OMIM

Phenylketonuria

cystic fibrosis

Down syndrome

Tay–Sachs

thalassaemias

FURTHER INFORMATION

Accessible Publishing of Genetic Information

Cambridge Genetics Knowledge Park, Public Health Genetics Unit: Education in genetics for health professionals

Contact a Family

Ethical, legal and social issues (ELSI) surrounding the availability of genetic information

Genetics Resources on the Web

National Coalition for Health Professional Education in Genetics

NHS Sickle Cell & Thalassaemia Screening Programme

UK newborn screening programme centre

US National Newborn Screening and Genetic Resource Center

US Office of Genomics and Disease Prevention

Victorian (Australian) Government Genetic Health Education Resources

Glossary

ATOPY

The genetic tendency to develop the classic allergic diseases — atopic dermatitis, allergic rhinitis (hay fever), and asthma.

BIOCHEMICAL GENETICS

The study of the relationships between genes and enzymes, specifically the role of genes in controlling the steps in biochemical pathways.

CYSTIC FIBROSIS

An inherited disease that affects sodium channels in the body and causes respiratory and digestive problems. Cystic fibrosis affects the mucus and sweat glands of the body. Thick mucus is formed in the breathing passages of the lungs and this predisposes affected persons to chronic lung infections.

HAEMOCHROMATOSIS

A hereditary disease characterized by improper processing of iron in the body. There is excessive absorption and storage of iron in affected individuals leading to damage of many organs including the liver and endocrine glands.

HYPERLIPIDAEMIAS

Elevation of certain types of serum lipoproteins which predisposes to atherosclerotic arterial disease.

PHENYLKETONURIA

An inborn error of metabolism caused by lack of the enzyme that converts phenylalanine to tyrosine. It causes abnormally high phenylalanine levels and severe, progressive mental retardation if untreated, but toxic effects can be prevented by neonatal screening and a low phenylalanine diet from an early age.

THALASSAEMIAS

Inherited disorders that are caused by the ineffective production of either the α- or β-globin chains of haemoglobin.

TRIMESTER

One of the three successive three-month periods into which a pregnancy can be devided for clinical purposes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qureshi, N., Modell, B. & Modell, M. Raising the profile of genetics in primary care. Nat Rev Genet 5, 783–790 (2004). https://doi.org/10.1038/nrg1453

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg1453

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing